Explore chapters and articles related to this topic
Urinary Tract Infections, Genital Ulcers and Syphilis
Published in Miriam Orcutt, Clare Shortall, Sarah Walpole, Aula Abbara, Sylvia Garry, Rita Issa, Alimuddin Zumla, Ibrahim Abubakar, Handbook of Refugee Health, 2021
Pyelonephritis is characterised by flank pain, fever with or without urinary symptoms, rigors, back pain and anorexia. Complications of pyelonephritis include renal abscess, sepsis and septic shock and renal impairment.
Inflammation and Infection
Published in Karl H. Pang, Nadir I. Osman, James W.F. Catto, Christopher R. Chapple, Basic Urological Sciences, 2021
Judith Hall, Christopher K. Harding
Complications of pyelonephritis:Sepsis, renal abscess, renal scarring, and emphysematous pyelonephritis
The Pathology of Human Schistosoma Haematobium Infection
Published in Max J. Miller, E. J. Love, Parasitic Diseases: Treatment and Control, 2020
Ureteritis cystic calcinosa is associated with S. haematobium infection, and is more frequent in severe urinary schistomiasis than mild disease. It is not associated with pyelonephritis.5,15 In Egypt, ureterolithiasis, but not nephrolithiasis, is also more common in patients with S. haematobium infections than in control subjects;5 here, the association between pyelonephritis and urolithiasis has been found.5,15 However, subsequent studies in other areas endemic for S. haematobium have failed to reveal an association between urinary schistosomiasis and urolithiasis.36–38 We conclude that the association found in Egypt is an epidemiologic, rather than a pathogenetic, relationship.1
Adverse events and complications after magnetic resonance-guided focused ultrasound (MRgFUS) therapy in uterine fibroids – a systematic review and future perspectives
Published in International Journal of Hyperthermia, 2023
Jakub Kociuba, Tomasz Łoziński, Magdalena Zgliczyńska, Maciej Byrczak, Salvatore Giovanni Vitale, Maciej Skrzypczak, Kornelia Zaręba, Michał Ciebiera
Other reported AEs included urinary tract infections or hematuria. Their potential pathophysiology is unknown. The authors of one analyzed study reported pyelonephritis that needed antibiotic therapy [32]. Some authors suggested cystitis related to Foley catheterization during the procedure, but the opinion was not supported by evidence [24,36]. Further investigation is needed to establish which patients are in the risk group for this AE and should receive prophylactic antibiotic therapy before the procedure. Vaginal discharge and bleeding or fibroid expulsion after the procedure were also mentioned in several cases (Table 1). Moreover, abdominal subcutaneous tissue and muscle edema were reported. However, they were only an MRI finding after the procedure without any or with minimal symptoms in almost all cases [33].
Comparison of Percutaneous Nephrostomy and Ureteral DJ Stent in Patients with Obstructive Pyelonephritis: A Retrospective Cohort Study
Published in Journal of Investigative Surgery, 2022
Hakan Anıl, Nevzat Can Şener, Kaan Karamık, İbrahim Erol, Ediz Vuruşkan, Hakan Erçil, Zafer Gökhan Gürbüz
The two most common drainage methods used for OP kidneys in urology practice are retrograde ureteral double J (DJ) stent insertion and percutaneous nephrostomy (PCN) placement. There is little proof to support the advantage of percutaneous nephrostomy over retrograde DJ stenting for obstructive pyelonephritis. In addition, there is not enough evidence for the superiority of the two methods over each other in terms of complications [4, 5]. Only one small randomized study compared the two different drainage methods and reported equal efficacy [6]. On the contrary, there is a little evidence that retrograde DJ stent placement increases bacteremia and nephrostomy should be preferred in OP cases [4]. The debate on the choice of drainage method in obstructive pyelonephritis remains difficult issue for clinicians.
Oral fosfomycin for treating lower urinary tract infections due to multidrug-resistant Escherichia coli in female adolescents
Published in Journal of Chemotherapy, 2022
Meltem Polat, Aslınur Ozkaya-Parlakay, Anıl Tapısız, Soner Sertan Kara, Selçuk Yüksel
Clinical cure (at 3-5 days post-treatment) was achieved in 68 (97%) patients, and control urine cultures yielded negative results in 66 (94%) patients. Two patients experienced microbiological failure, while the other two patients experienced both clinical and microbiological failure and treatment was switched to intravenous ertapenem. Two (3%) patients had UTI relapse after an initial response to oral FT. These patients were successfully treated with a 7-day course of intravenous ertapenem and a 5-day course of intramuscular amikacin. The clinical characteristics of the patients with clinical and microbiological failure and UTI relapse are summarized in Table 2. We could not find any underlying urinary tract abnormality or reason for the development of treatment failure or UTI relapse in five out of the six patients, while kidney stones were detected in one patient with a UTI relapse. Only two (3%) patients reported mild diarrhea, which appeared one to two days after administration of FT and resolved spontaneously within two days. No patient developed acute pyelonephritis or sepsis. Development of fosfomycin resistance was not detected in any patient with microbiological failure or UTI relapse.